Low dose poly I:C prevents diabetes in the diabetes prone BB rat

Journal of Autoimmunity

Volumn 11, Issue 4, 1998, Pages 343-352

  Sobel, Douglas O ^a,d   Goyal, Deepshika ^a   Ahvazi, Behrouz ^a   Yoon, Ji Won ^a,b   Chung, Young Hwa ^a,b   Bagg, Adam ^a   Harlan, David M ^a,c  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

^c NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

^d GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

BB rat; Cytokines; IDDM; Immunoregulatory cell; Poly I:C

Indexed keywords

POLYINOSINIC POLYCYTIDYLIC ACID;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; DOSE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; INTERFERON PRODUCTION; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE ACTIVATION;

EID: 0031723365     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1998.0203     Document Type: Article

References (45)

1. Nakhooda A.F., Like A.A., Chappel C.L., Murray F.T., Marliss E.B. 1976. The spontaneously diabetic Wistar rat: metabolic and morphologic studies. Diabetes 26: 100-112
2. Dyrberg T., Nakhooda A.F., Baekkeskov S., Lernmark A., Poussier P., Marliss E.B. 1982. Islet cell surface antibodies and lymphocyte antibodies in the spontaneous diabetic BB Wistar rat. Diabetes 311: 278-281
3. Mordes J.P., Desemone J., Rossini A. 1987. The BB rat. Diabetes Metab. Rev. 3: 725-750
4. Elder M.E., Maclaren N.K. 1983. Identification of profound peripheral T-lymphocyte immunodeficiencies in the spontaneously diabetic BB rat. J. Immunol. 130: 1723-1731
5. Prud'homme G., Fuks A., Colle E., Seemayer T.A., Guttman R.D. 1984. Immune dysfunction in diabetes prone BB rats. J. Exp. Med. 159: 463-478
6. Kikutani H., Makino S. 1992. The murine autoimmune diabetes model: NOD and related strains. Advances in Immunology 51: 285-322
7. Serreze D.V., Hamaguchi K., Leiter E.H. 1989. Immunomodulation circumvents diabetes in NOD/Lt mice. J. Autoimmunity 2: 759-776
8. Ewel C.E., Sobel D.O., Zeligs B.J., Bellanti J.A. 1992. Poly I:C accelerates development of diabetes mellitus in diabetes-prone BB rat. Diabetes 41: 1016-1021
9. Thomas V.A., Woda B.A., Handler E.S., Greiner D.L., Mordes J.P., Rossini A.A. 1991. Altered expression of diabetes in BB/Wor rats by exposure to viral pathogens. Diabetes 40: 255-258
10. Sobel D.O., Newsome J, Ewel C.H., Bellanti J.A., Abbassi V., Creswell K., Blair O. 1992. Poly I:C induces development of diabetes in BB rat. Diabetes 41: 515-520
11. Jacobs C., Young D., Tyler S., Callis G., Gillis S., Conlon P.J. 1988. In vivo treatment with IL-1 reduces the severity and duration of antigen-induced arthritis in rats. J. Immunol. 141: 2967-2974
12. Ely J.M., Greiner D.L., Lubaroff D.M., Fitch F.W. 1983. Characterization of monoclonal antibodies that define rat T cell alloantigens. J. Immunol. 130: 2798-2803
13. Rabinovitch A., Suarez W.L., Qin H-Y., Power R.F., Badger A.M. 1993. Prevention of diabetes and induction of nonspecific suppressor cell activity in the BB rat by an immunomodulatory Azaspirane, SK & F 106610. J. Autoimmunity 1: 39-49
14. Chomczynski P., Sacchi N. 1987. Single-step method of RNA isolation by acid guinidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159
15. Han H-S., Jun H-S., Utsugi T., Yoon J-W. 1996. A new type of CD4+suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice. J. Autoimm. 9: 331-339
16. Metroz-Dayer M-D., Mouland A., Brideau C., Duhamel D., Poussier P. 1990. Adoptive transfer of diabetes in BB rats induced by CD4 T lymphocytes. Diabetes 39: 928-932
17. Woda B.A., Biron C.A. 1986. Natural killer cell number and function in the spontaneously diabetic BB/W rat. J. Immunol. 137: 1860-1866
18. Like A.A., Anthony M., Guberski D.K., Rossini A.A. 1983. Spontaneous diabetes mellitus in the BB/W rat. Effects of glucocorticoids, cyclosporin A and antiserum to rat lymphocytes. Diabetes 32: 326-330
19. Yale J.F., Grose M., Seemayer T.A., Marliss E.B. 1985. Immunological and metabolic concomitants of cyclosporine prevention of diabetes in BB rats. Diabetes Research and Clinical Practice S610
20. Murase N., Lieberman I., Nalesnik M., Mintz D., Todo S., Drash A.L. 1990. Prevention of spontaneous diabetes in BB rats with FK-506. Lancet 336: 373-374
21. Like A.A., Biron C.A., Weringer E.S., Byman K.S., Sroczynski E., Guberski D.L. 1986. Prevention of diabetes in Bio Breeding/Worchester rats with monoclonal antibodies that recognize T lymphocytes or natural killer cells. J. Exp. Med. 164: 1145-1159
22. Oschilewski U., Kiesel U., Kolb H. 1985. Administration of silica prevents diabetes in BB rats. Diabetes 34: 197-199
23. Rabinovitch A. 1994. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation. Diabetes 43: 613-621
24. Fibbe W.E., Van Damme J., Billiau A., Duinkerken N., Lurvink E., Ralph P., Altrock B.W., Kaushansky K., Willemze R., Falkenburg J.H. 1988. Human fibroblasts produce granulocyte-CSF, macrophage-CSF, and granulocyte-macrophage-CSF following stimulation by interleukin 1 and poly (rI), poly (rC). Blood 72: 860-866
25. Akiyama Y, Stevenson G.W., Schlick E., Matsushima K., Miller P.J., Stevenson H.C. 1985. Differential ability of human blood monocyte subsets to release various cytokines. J. Leukocyte Biol. 37: 519-530
26. Tamura-Nishimura M, Sasukawa S. 1990. The roles of protein kinase and cyclic nucleotide dependent kinase in signal transduction in human interferon-gamma induction by poly I:C poly C. FEBS Lett. 261: 343-346
27. Gidlund M., Orn A., Wigzell H., Senik A, Gresser I. 1978. Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature 273: 759-761
28. Ishikura H., Kuchroo S., Abramson-Leeman S., Dorf M.E. 1988. Comparison between Helper and Suppressor T-cell Induction. Immunology Rev. 106: 93-114
29. Greiner D.L., Handler E.S., Nakano K., Mordes J.P., Rossini A.A. 1986. Absence of the RT-6T cell subset in diabetes prone BB/W rats. J. Immunol. 136: 148-151
30. + T lymphocytes induces diabetes in resistant BioBreeding Worcester (BB/W) rats. J. Exp. Med. 166: 461-475
31. Uchida A., Yanagawa E., Kokoschka E.M., Micksche M., Koren H.S. 1984. In vitro modulation of human natural killer cell activity by interferon: Generation of adherent suppressor cells. Eur. J. Cancer 50: 483-492
32. Sadelain M.W.J., Quin H.Y., Sumoski W., Parfrey N., Singh B., Rabinovitch A. 1990. Prevention of diabetes in the BB rat by early immunotherapy using Freund's adjuvant. J. Autoimmunity 3: 671-680
33. Qin H.Y., Suarez W.L., Parfrey N., Power R.F., Rabinovitch A. 1992. Mechanism of complete Freund's adjuvant protection against diabetes in BB rats: induction of nonspecific suppressor cells. Autoimmunity 12: 193-199
34. DeClerq E. 1987. Interferon induction by polynucleotides, modified polynucleotides and polycarboxylates. In Methods in Enzymology, Vol. 78, S. Petska, ed. Academic Press, New York, pp. 227-236
35. Wilson C.A., Jacobs C., Baker P., Baskin D.G., Dower S., Lernmark A., Toivola B., Vertrees S., Wilson D. 1990. IL-1 β modulation of spontaneous autoimmune diabetes and thyroiditis in the BB rat. J. Immunol 144: 3784-3788
36. Pukel C., Baquerizo H., Rabinovitch A. 1988. Destruction of rat islet cell monolayers by cytokines: synergistic interactions of interferon-gamma, tumor necrosis factor, lymphotoxin, and interleukin-1. Diabetes 37: 133-136
37. Chosich N., Rockett E., Harrison L.C. 1994. Endogenous TNF production differs between high and low diabetes incidence non-obese (NOD) mice. Autoimmunity 18: 163-168
38. Rothe H., Ongoren C., Martin S., Rosen P., Kolb H. 1994. Abnormal TNF-alpha production in diabetes-prone BB rats: enhanced TNF-alpha expression and defective PGE2 feedback inhibition. Immunology 81: 407-413
39. Yang X-D., Roland T., Singer S.M., Cao Z.A., Liblau R.S., Shreiber R.D., McDevitt H.O. 1994. Effect of tumor necrosis factor a on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J. Exp. Med. 180: 995-1004
40. Satoh J., Seino H., Abo T., Tanaka S., Shintani S., Ohta S., Tamura K., Sawai T., Nobunaga T., Oteki T., Kumagai K., Toyota T. 1989. Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in nonobese diabetic mice. J. Clin. Invest. 84: 1345-1348
41. Grewal I.S., Grewel K.D., Wong F.S., Picarella D.E., Janeway Jr C.A., Flavell R.A. 1996. Local expression of transgenic encoded TNF-α in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells. J. Exp. Med. 184: 1963-1974
42. Mason D., Fowell D. 1992. T cell subsets and autoimmunity. Curr. Opin. Immunol. 4: 728-732
43. Wogensen L., Lee M-S., Sarvetnick N. 1994. Production of intreleukin 10 by islet cells accelerates immune-mediated destruction of β cells in nonobese diabetic mice. j. Exp. Med. 179: 1379-1384
44. Moritani M., Yoshimoto K., Tashiro F., Hashimoto J., Miyazaki J., Li S. 1994. Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice. Int. Immunol. 6: 1927-1936
45. Balasa B., Sarvetnick N. 1996. The paradoxical effects of interleukin 10 in the immunoregulation of autoimmune diabetes. J. Autoimm. 9: 283-286